ICIs primarily function by blocking signaling pathways between tumor cells and immune cells, thereby relieving the inhibition of tumor cells by the immune system and reactivating immune cells to attack tumors, such as PD-1/PD-L1 inhibitors16. The gene discussed is CD274; the disease is neoplasm.